This Eindhoven-based startup is developing a new bioelectronic therapy for migraines; raises €26M
Salvia BioElectronics, a company that targets chronic migraine, has raised €26M in funding led by Panakes Partners, INKEF Capital, and SHS Gesellschaft fur Beteiligungsmanagement